Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 60760-666

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 60760-666). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (96f45871 7175 49d8 8374 Dfa2978d38c7 01)

Structural Formula (96f45871 7175 49d8 8374 Dfa2978d38c7 01)
Chemical structure of atorvastatin calcium showing the detailed molecular arrangement, including aromatic rings, hydroxyl groups, and calcium ions with water molecules as hydrate form.*
FDA Label Image

Figure1 (96f45871 7175 49d8 8374 Dfa2978d38c7 02)

Figure1 (96f45871 7175 49d8 8374 Dfa2978d38c7 02)
A line graph depicting cumulative incidence (%) over time in years for Atorvastatin calcium versus placebo. The solid line represents Atorvastatin, and the dashed line represents placebo, showing increasing incidence rates, with Atorvastatin consistently lower than placebo across approximately 3.5 years. Statistical values HR=0.64 (0.50-0.83) and p=0.0005 are noted in the graph.*
FDA Label Image

Figure2 (96f45871 7175 49d8 8374 Dfa2978d38c7 03)

Figure2 (96f45871 7175 49d8 8374 Dfa2978d38c7 03)
A cumulative hazard plot graph comparing Atorvastatin and Placebo over a 4-year follow-up period. The y-axis shows cumulative hazard percentage, while the x-axis shows time to first primary endpoint in years. The graph includes hazard ratio (HR 0.63) with confidence interval (0.48-0.83) and p-value (0.001), indicating statistical data comparison between the two groups.*
FDA Label Image

Figure3 (96f45871 7175 49d8 8374 Dfa2978d38c7 04)

Figure3 (96f45871 7175 49d8 8374 Dfa2978d38c7 04)
A line graph comparing the percentage of subjects experiencing the first major cardiovascular event over time (in years) for Atorvastatin 10 mg and 80 mg. The graph shows lower event rates for the 80 mg group, with corresponding hazard ratio (HR 0.78) and p-value (P=0.0002) indicated.*
FDA Label Image

60760-666 (Atorvastatin 60760 666 30)

60760-666 (Atorvastatin 60760 666 30)
Atorvastatin calcium 10 mg film-coated tablets label showing a quantity of 30 tablets. The label includes the NDC 60760-666-30, states it is manufactured by Lifestar Pharma LLC in Mahwah, NJ, made in India, and packaged by St. Mary's Medical Park Pharmacy in Oro Valley, AZ. The label also includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.